MedTrace Logo

A Better Choice for Patients Undergoing Endovascular Coil Embolization

NCT01722409 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2015-06-25

No results posted yet for this study

Summary

The investigators designed a double-blind, randomized placebo-controlled study to determine the effects of dexmedetomidine on the recovery characteristics of patients who were scheduled to undergo endovascular coil embolization.

Conditions

  • Intracranial Aneurysms

Interventions

DRUG

sevoflurane and 0.5 μg/kg dexmedetomidine

After induction of general anesthesia, Group DEX1 received a single dexmedetomidine dose of 0.5 μg/kg over 10 minutes.

DRUG

sevoflurane and 1 μg/kg dexmedetomidine

After induction of general anesthesia, Group DEX2 received a single dexmedetomidine dose of 1 μg/kg over 10 minutes.

Sponsors & Collaborators

  • China Medical University, China

    lead OTHER

Principal Investigators

  • Hong Ma, M.D.,PhD. · Dept. of Anesthesiology, the First Hospital of CMU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01722409 on ClinicalTrials.gov